Search
for
Sort by
Research 31–60 of 1000+
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- JAK Inhibitors: A New Weapon in the Skin Care Providers' Arsenal.
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Baricitinib-loaded EVs promote alopecia areata mouse hair regrowth by reducing JAK-STAT-mediated inflammation and promoting hair follicle regeneration
- Scarring hair follicle destruction is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up
- 63418 JAK3/TEC kinase pathways are active in alopecia areata lesions, and their inhibition with Ritlecitinib prevents αCD3/αCD28+IL-2 induced immune privilege collapse in healthy hair follicles ex vivo
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- 1359 Hair growth is induced by blockade of macrophage-derived oncostatin M and downstream JAK-STAT5 signaling in hair follicle stem cells
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Hair follicles as immune targets: unraveling cellular players, cytokine crosstalk, and precision pathways for future therapy of alopecia areata
- Alopecia areata
- Janus kinase inhibitors: An innovative treatment for alopecia areata
- Baricitinib for the Treatment of Alopecia Areata
- Immune therapies for alopecia areata: evidence and new perspectives